CMS New Tech Town Hall: Industry Insists Bonus Threshold Is Too High

Boston Scientific's Wingspan intracranial stent is the only product under consideration for a new technology add-on payment in fiscal year 2008, prompting stakeholders to complain that the opaqueness of CMS' criteria for awarding the bonus payment has deterred most firms from even applying